(Q43205091)

English

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

scientific article published in February 2010

Statements

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen (English)
1007; author reply 1008

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit